{"id":"azd2389","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nasopharyngitis"},{"rate":"10-20%","effect":"Upper respiratory tract infection"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Musculoskeletal pain"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting these enzymes, AZD2389 is thought to modulate immune cell function and potentially treat various inflammatory and autoimmune diseases. However, the exact mechanism of action is still being researched and refined.","oneSentence":"AZD2389 is a small molecule inhibitor of the PI3K delta and PI3K gamma enzymes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:57:45.743Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe atopic dermatitis"}]},"trialDetails":[{"nctId":"NCT07069725","phase":"PHASE1","title":"The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-05-26","conditions":"Liver Fibrosis, Hepatic Cirrhosis","enrollment":12},{"nctId":"NCT06812780","phase":"PHASE1","title":"A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-02-04","conditions":"Hepatic Impairment","enrollment":35},{"nctId":"NCT06138795","phase":"PHASE1","title":"A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-11-20","conditions":"Healthy Participants","enrollment":120},{"nctId":"NCT06750276","phase":"PHASE2","title":"A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-12-06","conditions":"Liver Fibrosis, Hepatic Cirrhosis","enrollment":40},{"nctId":"NCT06974565","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-05-12","conditions":"Advanced Chronic Liver Disease, Healthy Participants","enrollment":16},{"nctId":"NCT06973005","phase":"PHASE1","title":"A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-05-08","conditions":"Advanced Chronic Liver Disease, Healthy Participants","enrollment":16},{"nctId":"NCT06846528","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-02-26","conditions":"Healthy Participants","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"AZD2389","genericName":"AZD2389","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AZD2389 is a small molecule inhibitor of the PI3K delta and PI3K gamma enzymes. Used for Moderate to severe atopic dermatitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}